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a  b  s  t  r  a  c  t
Yucca  schidigera  Ortgies,  Asparagaceae,  is  a herbaceous  plant.  Due  to the  high  saponin  content  the
powdered  branches  and  leaves  are  used  as  natural  food  additive  for human  and  animal.  The aim of this
study  was to  investigate  the effects  of  Y.  schidigera  extracts  on  plasma  leptin,  ghrelin,  adiponectin,  insulin,
thyroid  hormones  and  some  biochemical  parameters  in  mice  fed  a  high-fat  diet.  Male  Swiss  Albino  mice
were  divided  into  seven  equal  groups.  Group  I (negative  control  group)  was  given  standard  diet;  Group
II  was  given  high-fat  diet; Group  III was  given  high-fat  diet with  carboxymethylcellulose;  Groups  IV–VII
were  given  hexane,  petroleum  ether,  ethyl  acetate,  and  methanol  extracts  of Y. schidigera  and  high-
fat  diet  via gastric  gavage  for 60 days.  High-fat  diet  signiﬁcantly  increased  plasma  leptin,  insulin,  freeeptin
besity
ice
T3 hormone,  glucose,  cholesterol,  low-density  lipoprotein,  triacylglyceride,  aspartate  aminotransferase
and  alanine  aminotransferase  levels,  and  signiﬁcantly  decreased  plasma  ghrelin,  adiponectin  and  free
T4 hormone  levels.  On  the  other  hand,  hormone  levels,  lipid proﬁle  and  biochemical  parameters  were
improved  by the  administration  of  the  PE  extract.  Y.  schidigera  extracts  could  be used as preventive
medicine  in  nutritional  disorders  via  regulating  energy  metabolism  and  hormonal  functions.
ileira© 2016  Sociedade  Bras
ntroduction
Yucca schidigera Ortgies is a herbaceous plant from the family
sparagaceae, native to the deserts of the south-western United
tates and northern Mexico. Due to the antiprotozoal and antifun-
al properties and hormone-stimulating effects it has been used
afely to enhance performance as feed material for livestock as
ell as food material for humans (Narutoshi, 1992). Moreover,
n recent researches, Y. schidigera has shown to possess antiox-
dant, anti-hypercholesterolemic, anticarcinogenic, antiarthritic,
nti-inﬂammatory, antiprotozoal, antifungal and antihypertensive
roperties. The plant was shown to have secondary metabolites
uch as eugenol, caffeic acid, rosmarinic acid and -tocopherol.
oreover, the dried and powdered plant material also contains
pproximately 10% steroidal saponins and is used commercially as
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a saponin source (Francis et al., 2002; Piacente et al., 2004; Enginar
et al., 2006; Kucukkurt and Dündar, 2013).
Saponins are a class of secondary metabolites found in several
plant species. More speciﬁcally, they produce soap-like foaming
when shaken in aqueous solutions, and, in terms of structure, one
or more hydrophilic glycoside moieties combined with a lipophilic
triterpene or steroidal aglycone. These compounds are used in
phytotherapy and in the cosmetic industry for their cytotoxic,
hemolytic, molluscicidal, anti-inﬂammatory, antifungal, antiyeast,
antibacterial and antiviral activities (Leung et al., 1997; Sen et al.,
1998; Bachran et al., 2006) as well as in the pharmaceutical
industry for the semi-synthesis of steroidal drugs (Chwalek et al.,
2006). Moreover, saponins stimulate luteinizing hormone release
leading to abortifacient properties (Francis et al., 2002), have
immunomodulatory potential (Sun et al., 2009), cytostatic and
cytotoxic effects (Bachran et al., 2008) and adjuvant properties for
vaccines (Sjolander et al., 1998). Due to their physiological proper-
ties, saponins are now expected to serve as functional components
in food. They have been reported to decrease plasma cholesterol
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n rats when added to their diets (Oakenfull, 1981; Sidhu and
akenfull, 1986).
Fatty diet, as well as imbalance between the food intake and
nergy expenditure are the factors affecting the prevalence of
besity (Altunkaynak, 2005; Milagro et al., 2006). Obesity and over-
eight pose a major risk for serious diet-related chronic diseases,
ncluding type-II diabetes, cardiovascular diseases, hypertension,
troke and certain forms of cancer. Leptin, insulin and T3 are among
he most important hormones to provide this balance (Otukonyong
t al., 2005). Leptin, an adipose tissue hormone, regulates body fat
ass and body weight by decreasing the appetite and increasing
nergy expenditure (Zabrocka et al., 2006).
The present study was planned to determine the effects of the
xtracts obtained from Y. schidigera,  which was reported to be rich
n saponins in the previous studies, on leptin, ghrelin, insulin and




Yucca schidigera Ortgies, Asparagaceae, standard powder
Sarsaponin 30® contains more than 8% steroidal saponin) was
urchased from Desert King International (San Diego, CA, USA).
reparation of the extracts
Y. schidigera powder (500 g) was successively extracted with
 l of hexane (HE), petroleum ether (PE), ethyl acetate (EA) and
ethanol (ME) by percolation method at room temperature. After
ompletion of extraction the extracts were ﬁltered and the solvent
as removed by distillation under reduced pressure and low tem-
erature (40–50 ◦C) on a rotary evaporator to give crude extracts.
xtracts were weighed and yield percentages were calculated as
7.93% for HE, 26.42% for PE, 11.02% for EA and 9.27% for ME.
nimals
Male Swiss Albino mice (25–35 g) were purchased from the
nimal breeding laboratories of Afyon Kocatepe University Experi-
ental Animal Research and Application Center (Afyon, Turkey).
he animals were allowed to acclimatize to the animal facility
or at least 7 day before experiment started. The room conditions
ere maintained in a 12 h light/12 h dark cycle at room tempera-
ure (25 ± 3 ◦C), with rodent standard diet and water provided ad
ibitum. A minimum of ten animals was used in each group. The
tudy was permitted by the Institutional Animal Ethics Committee
Ankara University Ethical Council Study Number: 2009/34) and
as performed according to the international rules considering the
nimal experiments and biodiversity right.
xperimental protocol
Two different control groups were employed in the study. The
egative control group was maintained on standard pellet diet and
ater ad libitum without administering any plant extract (negative
ontrol group). The high-fat diet (HFD) group received special diet
ontaining 40% beef tallow for eight weeks (HFD group-positive
ontrol). The vehicle control group received 0.5% CMC  suspension
n distilled water and was maintained on HFD (CMC group). On
he other hand, the experimental group animals received hexane
HE), petroleum ether (PE), ethyl acetate (EA), and methanol (ME)
xtracts obtained from Y. schidigera along with HFD. Extracts were
dministered orally after suspending in distilled water and 0.5%
odium carboxymethyl cellulose (CMC) by using a gastric gavage atarmacognosia 26 (2016) 246–250 247
100 mg/kg doses daily for eight weeks. This dose was determined
according to a previous preliminary study (Avci et al., 2006). Blood
samples were taken from the heart into tubes with heparin and
plasma was obtained at the end of the experimental period, then
centrifugation performed at 1500 × g (+4 ◦C) for 10 min  and kept at
−30 ◦C in advance of assays.
Biochemical analysis
Plasma leptin (Biovendor, Czech Republic, Cat No.
RD291001200R), insulin (Millipore, USA, Cat No. EZRMI-13K),
ghrelin (Millipore, USA, Cat No. EZRGRT-91K), total adinopectin
(Biovendor, Czech Republic, Cat No. RD293023100R), total tri-
iodothyronine (T3) (DRG International Inc., USA, Cat No. EIA-4569),
total tetra-iodothyronine (T4) (DRG International Inc., USA, Cat
No. EIA 4568), free tri-iodothyronine (FT3) (DRG International Inc.,
USA, Cat No. EIA-2385) and free tetra-iodothyronine (FT4) (DRG.
International Inc., USA, Cat No. EIA 2386) were measured using an
enzyme-linked immunosorbent assay (ELISA).
Liver damage was  assessed by the estimation of serum levels
of alanine aminotransferase (ALT), and aspartate aminotransferase
(AST) by using commercial kits Teco Diagnostics assay kit (Teco
Diagnostics, CA, USA). Serum levels of total protein (Tp), urea,
total cholesterol (Tc), glucose, low density lipoprotein-cholesterol
(LDL-c), high density lipoprotein-cholesterol (HDL-c) and triacyl-
glyceride (Tg) were determined using COBAS test kits (Roche
Diagnostics Systems, Istanbul, Turkey) according to the manu-
facturers’ instructions in Laboratory of Biochemistry, Faculty of
Veterinary Medicine, University of Afyon Kocatepe (Turkey).
Statistical analysis of data
The data obtained from the animal experiments was  expressed
as mean and standard error (±SEM). The statistical differences
among the experimental groups were evaluated by one-way
ANOVA and Duncan post hoc tests using the SPSS computer soft-
ware program. A difference of p < 0.05 in the mean values was
considered signiﬁcant.
Results
Body weights of the mice are shown in Table 1. Supplementation
of HFD to the animals during eight weeks signiﬁcantly increased
the body weight compared to the control group (p < 0.05). On the
other hand, during the experimental period PE extract prevented
the weight gain of mice compared to the other groups.
Plasma glucose, TC, LDL, HDL, TG, AST, and ALP were found to be
high in HFD and CMC  + HFD groups compared to the control group
(p < 0.05) as shown in Table 2. On the other hand, administration
of 100 mg/kg Y. schidigera extracts, especially HE and PE, decreased
the levels of these parameters (p < 0.05). These results suggest that
Y. schidigera extracts have capacity to alleviate the biochemical
status caused by HFD.
Supplementation of HFD increased leptin, insulin, and FT3
whereas decreased ghrelin, adiponectin, and FT4 (p < 0.05). In addi-
tion, TT4 and TT3 levels were not changed in all groups (Table 3). On
the other hand, administration of 100 mg/kg Y. schidigera extracts
especially PE resulted in reversal of HFD-induced hormone levels
(p < 0.05). These results suggest that Y. schidigera extracts affected
hormone status.Discussion
Although in some studies it was  shown that HFD does not affect
weight gain (Gao et al., 2002), in our study it was observed that
248 I. Kucukkurt et al. / Revista Brasileira de Farmacognosia 26 (2016) 246–250
Table 1
The effects of Yucca shidigera extracts on body weight in mice (n: 15; mean ± SEM).
Groups 0 day 15 day 30 day 45 day 60 day p value
Control 25.43 ± 0.75 25.57 ± 0.67 25.17 ± 0.69 25.61 ± 0.87 26.00 ± 0.99 0.966
HFD  26.44 ± 0.79c 29.44 ± 1.02b 32.27 ± 1.20b 35.40 ± 1.06a 36.90 ± 1.18a 0.000
HFD  + CMC  26.19 ± 0.82c 29.61 ± 1.21b 31.86 ± 1.28b 36.16 ± 0.93a 36.63 ± 1.21a 0.000
HE  extract 25.86 ± 1.06b 30.85 ± 0.98a 29.47 ± 1.44a 30.01 ± 1.10a 30.08 ± 0.98a 0.038
PE  extract 26.93 ± 1.36 30.31 ± 1.77 30.20 ± 0.89 30.81 ± 0.88 30.68 ± 1.04 0.083
EA  extract 27.87 ± 1.49b 31.60 ± 1.42a 31.76 ± 1.26a 33.86 ± 1.08a 34.19 ± 1.08a 0.012
ME  extract 26.17 ± 0.87b 33.31 ± 0.74a 33.27 ± 0.77a 33.90 ± 0.72a 34.64 ± 0.72a 0.000
a,b,c Values with different letters within a column are signiﬁcantly different by Duncan’s multiple range test.
HE,  hexane; PE, petroleum ether; EA, ethyl acetate; ME,  methanol.
Table 2
The effects of Yucca schidigera extracts on blood biochemical parameters in mice (n: 15; mean ± SEM).
Groups Glucose (mg/dl) Tc (mg/dl) LDL-c (mg/dl) HDL-c (mg/dl) Tg (mg/dl) Tp (g/dl) AST (U/L) ALT (U/L)
Control 103.6 ± 2.50cd 88.71 ± 2.69c 22.30 ± 2.59c 85.66 ± 2.45c 64.37 ± 3.16bc 4.30 ± 0.08 39.34 ± 4.09b 164.1 ± 11.3b
HFD 163.7 ± 9.28a* 189.1 ± 8.45a* 66.7 ± 6.47a* 116.8 ± 2.71b* 99.85 ± 4.25a* 4.34 ± 0.15 76.19 ± 4.48a* 235.5 ± 23.8a*
HFD + CMC  179.5 ± 7.47a 197.6 ± 14.31a 70.6 ± 3.13a 118.2 ± 4.37b 102.9 ± 5.14a 4.37 ± 0.12 71.68 ± 5.02a 241.7 ± 20.1a
HE extract 91.03 ± 3.01d 137.7 ± 8.65b 49.32 ± 1.99b 139.1 ± 6.09a 76.00 ± 4.55b 4.83 ± 0.12 36.28 ± 2.93b 173.1 ± 13.1b
PE extract 118.2 ± 7.35c 129.3 ± 5.29b 42.97 ± 1.48b 111.3 ± 3.96b 66.71 ± 3.74bc 4.77 ± 0.12 46.26 ± 2.42b 179.3 ± 12.1b
EA extract 124.1 ± 7.17c 128.2 ± 3.06b 62.64 ± 4.94a 108.6 ± 3.61b 57.01 ± 5.01c 4.50 ± 0.18 36.80 ± 2.97b 173.9 ± 14.6b
ME extract 148.4 ± 13.2b 148.5 ± 6.81b 65.0 ± 3.97a 124.4 ± 9.03b 66.43 ± 6.82bc 4.31 ± 0.23 44.09 ± 2.99b 180.1 ± 10.8b
p value 0.000 0.000 0.000 0.000 0.000 0.067 0.000 0.003




























H,b,c Values with different letters within a column are signiﬁcantly different by Dunc
E,  hexane; PE, petroleum ether; EA, ethyl acetate; ME,  methanol.
ice given fat exhibited weight gain as in the long term studies
arried out with HFD (Cha et al., 2000). Compared to the control
roup, the increase in 15 days live weight was found to be statisti-
ally signiﬁcant in all groups but the PE and HE groups. The other
easurements were also supported these data.
Although body fat index and body mass index are the major
eterminants of leptin levels, insulin, glucocorticoids and pro-
actin stimulate leptin synthesis while NPL, thyroid hormones, GH,
omatostatin, free fatty acids and long exposure to cold inhibit it
Kucukkurt, 2015). In a previous study by I˙s¸ bilen et al. (2007) HFD
ed rats during ﬁve weeks, the plasma, aort and liver leptin levels
ncreased. Similarly, in our study, plasma leptin levels increased in
he high-fat diet and CMC  groups. In Y. schidigera extract groups,
owever, leptin levels decreased signiﬁcantly although mice were
ed a high-fat diet. The decrease of leptin levels in the extract groups
nd increase in high-fat diet groups were parallel with the changes
n the live-weight as shown in Table 1. Indeed, Kim et al. (2005)
ed the rats with high-fat diet for eight weeks and then reﬁned
he steroidal saponins in Red Korean Ginseng, which is considered
s a steroidal saponin source like Y. schidigera,  and administered
t intraperitoneally for three weeks at a dose of 200 mg/kg/day.
t the end of the study, it was noted that plasma leptin levels
ecreased signiﬁcantly in the animals that were given saponin,
able 3
he effects of Yucca schidigera extracts on some hormones in mice (n: 15; mean ± SEM).
Groups Leptin (ng/ml) Ghrelin (mg/dl) Adiponectin (mg/dl) Insulin
Control 28.14 ± 1.75b 1.21 ± 0.05a 1.41 ± 0.13a 0.44 ±
HFD 57.41 ± 4.13a* 0.79 ± 0.06b* 0.79 ± 0.09b* 2.07 ±
HFD + CMC  54.24 ± 4.81a 0.73 ± 0.04b 0.81 ± 0.11b 2.21 ±
HE extract 36.55 ± 2.04b 0.81 ± 0.04b 1.49 ± 0.12a 0.56 ±
PE extract 36.05 ± 3.13b 1.38 ± 0.07a 1.52 ± 0.08a 0.80 ±
EA extract 37.81 ± 5.72b 0.77 ± 0.07b 1.21 ± 0.11a 0.84 ±
ME extract 35.39 ± 2.27b 0.75 ± 0.09b 1.46 ± 0.10a 0.79 ±
p value 0.000 0.000 0.000 0.000 
* HFD group is statistically different compared to the control group (p < 0.05).
,b,c Values with different letters within a column are signiﬁcantly different by Duncan’s m
E,  hexane; PE, petroleum ether; EA, ethyl acetate; ME,  methanol.ultiple range test (p < 0.05).
and the researchers suggested that this could be due to the fact
that saponin resulted in decrease in live-weight and body fat mass.
In another study by the same researchers, protopanaxadiol and
protopanaxatriol-type saponins from Red Ginseng were adminis-
tered to the rats fed a HFD at 50 mg/kg/day dose. It was  reported that
the decrease in plasma leptin levels could be attributed to thermo-
genesis properties of the saponins (Kim et al., 2009). The mentioned
researches on the activity of the saponins on the leptin levels, sup-
ported our results which reveal a decrease in body fat mass in mice
with the administration of Y. schidigera extracts.
Consistent with these ﬁndings, in our study, both ghrelin and
adinopectin levels decreased signiﬁcantly in the mice fed a HFD
compared to the control group. Ghrelin levels increased in the
PE and HE groups while they did not change in the other extract
groups. This increase in the PE and HE groups is consistent with
the decrease in leptin levels and live-weight. In the other extract
groups, no change was seen in ghrelin hormone levels compared
to the HFD group and in these groups live-weight decrease was
not similar to that in the PE and HE groups. In our study, insulin
hormone increased statistically, particularly in the HFD and CMC
groups. Increase in insulin reﬂects that blood glucose was stored
as glycogen in the liver and as fatty acids in the adipose tissue
(Bays¸ u Sözbilir and Bays¸ u, 2008). Increase in adipose tissue also
 (ng/ml) TT4 (g/dl) ST4 (ng/ml) TT3 (g/dl) ST3 (pg/ml)
 0.05c 34.45 ± 3.45 0.36 ± 0.04a 18.33 ± 0.15 1.91 ± 0.05b
 0.24a* 41.39 ± 1.22 0.14 ± 0.02b* 18.58 ± 0.14 3.52 ± 0.33a*
 0.15a 42.44 ± 2.47 0.15 ± 0.02b 18.90 ± 0.26 3.03 ± 0.31a
 0.11bc 36.89 ± 1.53 0.42 ± 0.04a 18.41 ± 0.04 3.25 ± 0.17a
 0.04bc 43.54 ± 2.57 0.49 ± 0.05a 18.44 ± 0.03 3.26 ± 0.09a
 0.04b 43.70 ± 3.37 0.50 ± 0.04a 18.47 ± 0.09 3.16 ± 0.18a
 0.12bc 40.02 ± 2.88 0.44 ± 0.07a 18.45 ± 0.05 3.19 ± 0.07a
0.126 0.000 0.098 0.000
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ncreases leptin hormone levels in the blood (Patel et al., 1998).
rinivasan et al. (2005) reported that body weight increases in rats
ed a HFD, which leads to increase in plasma glucose, triacylglyc-
ride, total cholesterol and insulin levels compared to the control
roup. Besides, Winzell and Ahren (2004) studied the effect of HFD
nd reported that insulin levels increase in mice parallel to feed-
ng on a HFD. In the present study, the same situation was  seen in
he HFD group, however, insulin levels decreased in the Y. schidig-
ra extract administered-groups suggesting that active ingredients
ound in extracts may  probably play a role in this action. A review
y Margetic et al. revealed that many studies conducted in humans
nd rats suggest that hyperinsulinemic conditions increase plasma
eptin levels. Patel et al. (1998) reported that plasma leptin lev-
ls decrease in diabetic rats, but administration of insulin acts by
ncreasing plasma leptin levels. Our ﬁndings are found to be in
ccord with those previous data.
Considering thyroid hormone measurements, although in our
tudy there was not any difference between the total T4 and T3 and
ree T3 levels increased, free T4 hormone decreased in the Y. schidi-
era extract groups compared to the HFD and CMC  groups and we
id not note any change compared to control group. Our previous
tudy shows that escin which contains saponin effects serum T3
nd T4 levels in HFD fed mice (Avci et al., 2010). Although we  did
ot spot any study in literature that focus especially on saponins
nd thyroid hormones, there are data suggesting that short- and
ong-term use of natural and synthetic ﬂavanoids cause decrease in
lasma T3 and T4 levels (Van der Heidi et al., 2003). Fain et al. (1997)
ound that administration of T3 to hypothyroid rats decreased lep-
in mRNA levels by 40% at the 8th hour; therefore, they suggested
igh thyroid hormone levels can diminish leptin levels. Zabrocka
t al. (2006) showed that serum leptin levels and white adipose
issue mRNA levels that are considered as indicators of leptin syn-
hesis decrease in rats, to which they had given various amounts of
3. In some studies, however, no correlation was reported between
hyroid hormones and leptin (Friedman and Halaas, 1998).
Studies show that HFD increases ALT and AST levels in the blood
Friedman et al., 1996). In this study, it was also observed that
lasma AST and ALT levels increased and this increase was less in
he Y. schidigera plant extract groups. The plant Y. schidigera con-
ains mainly steroidal saponins as well as vegetal chemicals such
s phenolic substances, ﬁber, resveratrol and stilbens in its dry
atter and these saponins are widely used in industry and stock-
reeding (Kucukkurt and Dündar, 2013). It was showed in several
tudies that plants containing saponin act by reducing the absorp-
ion of nutritions in the digestive tract and can alter metabolism
y this route. Y. schidigera lowers lipid metabolism and blood glu-
ose levels. It is thought that these effects of saponins are revealed
hen taken in small amounts and they particularly alter normal
bsorption of lipids and glucose in the digestive tract (Kucukkurt
nd Dündar, 2013). Y. schidigera acts on lipid metabolism and low-
rs cholesterol, LDL and triacylglyceride levels (Kim et al., 2003;
ucukkurt et al., 2011). When the extract groups were taken into
ccount, the lowest value that decreased glucose levels of all the
roups was the HE-administered group. While a decrease in choles-
erol and triacylglyceride levels was noted in all the extract groups,
DL levels decreased only in the HE and PE groups. Findings in this
tudy indicate the effect of Y. schidigera on lipid metabolism and
imilar results were also obtained in the other studies (Ince et al.,
013; Kucukkurt and Dündar, 2013). Here, Y. schidigera generated
 regulatory effect on the lipid proﬁle and lipid metabolism by reg-
lating hepatic functions. As a conclusion, extracts obtained from
. schidigera can be used for the prevention of the diseases caused
y HDF and regulation of the energy metabolism and hormonal
unctions. Petroleum ether and hexane extracts exert the most sig-
iﬁcant effect, yet, further studies should be conducted to reveal
he active secondary metabolites.armacognosia 26 (2016) 246–250 249
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